DNER and diabetic kidney disease: Moreover, MS417 as a bromodomain and extraterminal (BET)-specific bromodomain inhibitor can attenuate proteinuria in DKD via blocking acetylation-mediated association of p65 and STAT3 with BET proteins [128].